- Appropriate candidates for statin use in heart failure
-
Seo HS
- KMID: 2070129
- Korean J Intern Med.
- 2014 Nov;29(6):730-734.
- doi: 10.3904/kjim.2014.29.6.730
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Myocardial Protective Effect of Tezosentan, an Endothelin Receptor Antagonist, for Ischemia-Reperfusion Injury in Experimental Heart Failure Models
-
Ryu SM, Kim HJ, Cho KR, Jo WM
- KMID: 1781994
- J Korean Med Sci.
- 2009 Oct;24(5):782-788.
- doi: 10.3346/jkms.2009.24.5.782
The myocardial protective effects of endothelin antagonist in ischemic cardiomyopathy (ICMP), doxorubicin-induced cardiomyopathy (DOX) and pressure-overload hypertrophy by transverse aortic constriction (TAC) models have been predicted to be different. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial
-
Yang W, Zhou YJ, Fu Y, Qin J, Qin S, Chen XM, Guo JC, Wang DZ, Zhan H, Li J, He JY, Hua Q
- KMID: 2374195
- Yonsei Med J.
- 2017 Jan;58(1):105-113.
- doi: 10.3349/ymj.2017.58.1.105
PURPOSE: Urapidil is putatively effective for patients with hypertension and acute heart failure, although randomized controlled trials thereon are lacking. We investigated the efficacy and safety of intravenous urapidil relative... -
- CITED
-
- Close
- SHARE
-
- Close
